Home/Filings/4/0001209191-16-136041
4//SEC Filing

MEI Pharma, Inc. 4

Accession 0001209191-16-136041

$LITSCIK 0001262104operating

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 2:45 PM ET

Size

5.7 KB

Accession

0001209191-16-136041

Insider Transaction Report

Form 4
Period: 2016-08-05
Zech Thomas M.
Chief Financial Officer
Transactions
  • Award

    Restricted stock units

    2016-08-05+17,12317,123 total
    Common Stock par value $0.00000002 (17,123 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the registrant's Common Stock.
  • [F2]Each restricted stock unit becomes 100% vested on August 5, 2018. Settlement of vested restricted stock units, in shares of Common Stock, shall occur within 5 days of vesting.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001262104

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 2:45 PM ET
Size
5.7 KB